Willingdon Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $2K | Sell |
20
-4
| -17% | -$400 | ﹤0.01% | 256 |
|
|
2019
Q4 | $2K | Hold |
24
| – | – | ﹤0.01% | 334 |
|
|
2019
Q3 | $2K | Buy |
24
+4
| +20% | +$333 | ﹤0.01% | 371 |
|
|
2019
Q2 | $2K | Sell |
20
-4,805
| -100% | -$481K | ﹤0.01% | 283 |
|
|
2019
Q1 | $437K | Buy |
4,825
+151
| +3% | +$13.7K | 0.11% | 110 |
|
|
2018
Q4 | $335K | Buy |
4,674
+299
| +7% | +$21.4K | 0.1% | 124 |
|
|
2018
Q3 | $419K | Buy |
4,375
+167
| +4% | +$16K | 0.11% | 108 |
|
|
2018
Q2 | $401K | Buy |
4,208
+46
| +1% | +$4.38K | 0.12% | 110 |
|
|
2018
Q1 | $365K | Buy |
4,162
+221
| +6% | +$19.4K | 0.12% | 114 |
|
|
2017
Q4 | $334K | Sell |
3,941
-3,109
| -44% | -$263K | 0.11% | 108 |
|
|
2017
Q3 | $610K | Buy |
7,050
+509
| +8% | +$44K | 0.22% | 92 |
|
|
2017
Q2 | $505K | Buy |
6,541
+118
| +2% | +$9.11K | 0.2% | 108 |
|
|
2017
Q1 | $445K | Sell |
6,423
-440
| -6% | -$30.5K | 0.18% | 104 |
|
|
2016
Q4 | $406K | Sell |
6,863
-67
| -1% | -$3.96K | 0.19% | 103 |
|
|
2016
Q3 | $460K | Buy |
6,930
+752
| +12% | +$49.9K | 0.23% | 105 |
|
|
2016
Q2 | $334K | Buy |
+6,178
| New | +$334K | 0.17% | 109 |
|